🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in users injecting products of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

According to the social media company, the platform has taken down violative content and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.

After moments of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Product Details and Pricing

Within these communities, posts display dark colored packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to potentially serious health risks”.